FDA selects Eli Lilly and Regeneron for PreCheck, targeting up to 14 months sooner reviews
The PreCheck program lets FDA assess drug facilities during construction, potentially shaving massive time off approval timelines.
By Hessa Al-Faleh·· 3 min

Curating from trusted global sources…
2 briefings · “regeneron”
The PreCheck program lets FDA assess drug facilities during construction, potentially shaving massive time off approval timelines.

The PreCheck Pilot brings seven early adopters into a faster FDA path for new manufacturing facilities, changing the timeline games.